Development of a point of care diagnostic to guide efficient usage of blood produ

Ended Project Grant Awarded Last action

Award ID
R44HL103030
Recipient
Awarding agency
Obligated
$4,189,477

Award facts

Assistance listing
93.837 Cardiovascular Diseases Research
Completion date
Originally
Place of performance
Charlottesville, VA, USA

Award details come from USAspending.gov.

Transactions

Action Obligated Date
Amendment -$27,955
Amendment BIO - supplement - description (provided by applicant): the problem: the inability of blood to coagulate properly represents a major source of preventable… -$27,955
Amendment -$1,054,277
Amendment $1,054,277
Amendment $5,000
Amendment $999,617
Amendment $1,054,368
Amendment -$1,054,277
Amendment -$5,000
Amendment -$1,054,368
Amendment -$999,617
Amendment $1,054,277
Amendment $999,617
Amendment $5,000
Amendment Development of a POC device to guide efficient use of blood products $999,708
Amendment BIO - supplement $1,186,785
Amendment $98,565
Original award $955,712
Show all 18

Quick answers

Who received award R44HL103030?

R44HL103030 was awarded to Hemosonics, LLC by National Heart Lung and Blood Institute (National Institutes of Health) on August 6, 2010.

How much is award R44HL103030 worth?

$4,189,477 has been obligated on R44HL103030.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award